Aortic endocarditis caused by gentamicin-resistant Enterococcus faecalis. 1988

M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
Division of Infectious Diseases and Clinical Microbiology, Fundación Jiménez Díaz, Madrid, Spain.

A case is reported of a patient who developed aortic endocarditis after protracted hospitalization during which time the patient received multiple courses of aminoglycoside and cephalosporin therapy. The infecting organism, an Enterococcus faecalis strain, was resistant to gentamicin and to the combination of ampicillin with gentamicin. Valve replacement was performed after four weeks of therapy with ampicillin, and enterococci were isolated from cardiac vegetations. Valve replacement may be necessary to achieve cure of endocarditis due to enterococci highly resistant to gentamicin.

UI MeSH Term Description Entries
D008297 Male Males
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D004697 Endocarditis, Bacterial Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use. Bacterial Endocarditides,Bacterial Endocarditis,Endocarditides, Bacterial
D005839 Gentamicins A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS. Gentamicin Sulfate (USP),Gentamycin,G-Myticin,Garamycin,Gentacycol,Gentamicin,Gentamicin Sulfate,Gentamycins,Gentavet,Genticin,G Myticin,GMyticin,Sulfate, Gentamicin
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000667 Ampicillin Semi-synthetic derivative of penicillin that functions as an orally active broad-spectrum antibiotic. Penicillin, Aminobenzyl,Amcill,Aminobenzylpenicillin,Ampicillin Sodium,Ampicillin Trihydrate,Antibiotic KS-R1,Omnipen,Pentrexyl,Polycillin,Ukapen,Aminobenzyl Penicillin,Antibiotic KS R1,KS-R1, Antibiotic,Sodium, Ampicillin,Trihydrate, Ampicillin
D001021 Aortic Valve The valve between the left ventricle and the ascending aorta which prevents backflow into the left ventricle. Aortic Valves,Valve, Aortic,Valves, Aortic

Related Publications

M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
February 1995, Postgraduate medical journal,
M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
August 1991, Antimicrobial agents and chemotherapy,
M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
May 1998, The Journal of infection,
M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
January 2007, Scandinavian journal of infectious diseases,
M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
January 2004, Texas Heart Institute journal,
M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
August 2013, Antimicrobial agents and chemotherapy,
M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
October 2000, Journal of chemotherapy (Florence, Italy),
M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
October 2008, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas,
M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
June 1991, The Journal of infectious diseases,
M L Fernández-Guerrero, and C Barros, and J L Rodriguez Tudela, and R Fernández Roblas, and F Soriano
August 2013, Current infectious disease reports,
Copied contents to your clipboard!